On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

NetworkNewsAudio – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) Interview

Company: Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF)
Category: Interviews

About Veritas Pharma Inc.

Veritas Pharma Inc. is an emerging pharmaceutical and IP development company publicly traded in Canada, the United States and Germany. Through its recently acquired 80 percent stake in Cannevert Therapeutics Ltd., also known as Veritas’ R&D arm, the company is clinically profiling various cannabis cultivars to pharmacologically connect unique strains with specific disease conditions. Veritas Pharma’s goal is to perform clinical trials to prove the efficacy of the designated lead cannabis strains and to market the clinically effective cultivars as prescription medicines in a fast-track protocol.

View Complete Profile

Contact us: 212.418.1217